Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy - Top-Institutions - MDSpire

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy

  • By

  • Alexander Casimir Angleitner

  • Markus Maulhardt

  • Gerald Wulf

  • Judith Büntzel

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Medical Center Göttingen
    University Medical Center Göttingen

    Göttingen, Lower Saxony

    Key Differentiators

    • Hematology Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology Oncology

  • #3

    Tongji Hospital
    Tongji Hospital

    Wuhan, Hubei

    Key Differentiators

    • Hematology Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology Oncology

Original Source(s)

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy

  • by Alexander Casimir Angleitner, Markus Maulhardt, Gerald Wulf, Judith Büntzel

  • June 11, 2026

Related Content

Editorial: Integrating nutrition in cancer therapy: approaches to improve patient outcomes and survival

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib

The unheard pain: why patient-related barriers remain the weakest link in cancer pain management